American Express shareholders overwhelmingly defeated a shareholder resolution to examine the company’s coverage for sex-reassignment drugs and surgeries for underage patients, with 99.57% voting against the proposal.

American Express shareholders overwhelmingly defeated a shareholder resolution to examine the company’s coverage for sex-reassignment drugs and surgeries for underage patients, with 99.57% voting against the proposal.

Go to News Site